MyFinsight
Home
Blog
About
Proceeds from the sale and
maturities of investments
$100,000K
(-60.83%↓ Y/Y)
Net income
$37,414K
(-16.59%↓ Y/Y)
Deferred income tax
$11,110K
Accounts receivable, net
-$8,037K
(-326.59%↓ Y/Y)
Proceeds from issuance of
common shares for...
$58,441K
(451.85%↑ Y/Y)
Net cash and cash
equivalents acquired in...
-$5,212K
Amortization and
depreciation
$4,834K
(-50.27%↓ Y/Y)
Share-based compensation
$2,839K
(39.78%↑ Y/Y)
Inventory
-$1,259K
(-117.31%↓ Y/Y)
Deferred revenue
$624K
(-87.88%↓ Y/Y)
Accrued expenses and
other liabilities
$561K
(103.27%↑ Y/Y)
Proceeds from issuance of
common shares under...
$363K
(-9.48%↓ Y/Y)
Cash flows from
investing activities
$81,448K
(358.63%↑ Y/Y)
Cash flows from
operating activities
$52,566K
(15.43%↑ Y/Y)
Cash flows from
financing activities
$4,810K
(105.13%↑ Y/Y)
Canceled cashflow
$23,764K
Canceled cashflow
$14,112K
Canceled cashflow
$53,994K
Net increase
(decrease) in cash, cash...
$138,824K
(556.19%↑ Y/Y)
Purchases of investments
$23,764K
(-89.99%↓ Y/Y)
Prepaid expenses and
other current assets
$5,981K
(217.14%↑ Y/Y)
Accounts payable
-$2,799K
(-49.28%↓ Y/Y)
Other, net
$2,663K
(164.45%↑ Y/Y)
Net amortization of
premiums and discounts on...
$1,881K
(-63.96%↓ Y/Y)
Foreign exchange (gain)
loss on revaluation...
$561K
(106.06%↑ Y/Y)
Operating lease
liabilities
-$227K
(42.53%↑ Y/Y)
Purchase of common shares
under share...
$38,715K
(-56.74%↓ Y/Y)
Tax withholding
payments related to net...
$11,874K
(31.41%↑ Y/Y)
Payments of principal
portion of monoplant...
$3,405K
(-45.09%↓ Y/Y)
Back
Back
Cash Flow
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)
source: myfinsight.com